Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer

Photodynamic therapy is an emerging treatment modality that is under, intensive preclinical and clinical investigations for many types of disease including cancer. Despite the promise, there is a lack of a reliable drug delivery vehicle that can transport photosensitizers (PSs) to tumors in a site-specific manner: Previous efforts have been focused on polymer- or liposome-based nanocarriers, which are usually associated with a suboptimal PS loading rate and a large particle size. We report herein that a RGD4C-modified ferritin (RFRT), a protein-based nanoparticle, can serve as a safe and efficient PS vehicle. Zinc hexadecafluorophthalocyanine (ZnF16Pc), a potent PS with a high 102 quantum yield but poor water solubility, can be encapsulated into RFRTs with a loading rate as high as similar to 60 wt % (i.e, 13 mg of ZnF16Pc can be loaded on 1 mg of RAM), which far exceeds those reported previously.. Despite the high loading, the ZnF16Pc-loaded Fans (P-RFRTs) show an overall particle size of 18.6 +/- 2.6 nm, which is significantly smaller than other PS-nanocarrier conjugates: When tested on U87MG subcutaneous tumor models, P-RFRTs showed a high tumor accumulation rate (tumor-to-normal tissue ratio of 26.82 +/- 4.07at 24 h), a good tumor inhibition rate (8164% on day 12), as well as minimal toxicity to the skin and other major organs. This technology can be extended to deliver other metal-containing PSs and holds great clinical translation potential.